Why is diversity important in drug evaluations?

Diversity is crucial in drug evaluations because it ensures that therapies are safe and effective across different population groups, enhancing generalizability and improving health outcomes.

How can we improve participation from underrepresented groups?

Improving participation can be achieved through community engagement initiatives, partnerships with local organizations, and culturally competent outreach strategies.

What role do CROs play in fostering diversity?

CROs like InfinixBio support the design and execution of clinical trials that prioritize diversity, helping clients develop protocols that are inclusive and reflective of the patient population.